secwatch.observer — SEC 8-K summary
======================================

Issuer:     PANACEA LIFE SCIENCES HOLDINGS, INC. (PLSH)
CIK:        0001552189
Form:       8-K
Filed at:   2021-11-24T23:59:59+00:00
Accession:  0001493152-21-029840
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Panacea Life Sciences secures $1M via convertible note and warrant sale to Lincoln Park Capital
--------------------------------------------------------------------------------

- Sold $1.1M senior convertible note (net $1M) and warrants for 785,715 shares at $1.40 to Lincoln Park Capital Fund.
- Note due Nov 18, 2022; 12% interest if SEC filings missed, 18% on default; conversion at $1.40.
- Warrants exercisable from May 18, 2022 for 5 years at $1.40; 4.99% beneficial ownership cap.
- Investor may buy an additional $1.1M note and warrants on same terms within 91 business days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1552189/000149315221029840/0001493152-21-029840-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1552189/000149315221029840/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-029840

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer